Roche Holding AG
SIX:ROG
Roche Holding AG
Other Current Assets
Roche Holding AG
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Roche Holding AG
SIX:ROG
|
Other Current Assets
CHf3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
9%
|
CAGR 10-Years
5%
|
|
Novartis AG
SIX:NOVN
|
Other Current Assets
$2.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-3%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Other Current Assets
$260k
|
CAGR 3-Years
33%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Other Current Assets
$134m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Other Current Assets?
Other Current Assets
3.8B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Other Current Assets amounts to 3.8B CHF.
What is Roche Holding AG's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
5%
Over the last year, the Other Current Assets growth was 8%. The average annual Other Current Assets growth rates for Roche Holding AG have been 7% over the past three years , 9% over the past five years , and 5% over the past ten years .